 Connection
Mark Boguniewicz to Anti-Inflammatory Agents, Non-Steroidal
This is a "connection" page, showing publications Mark Boguniewicz has written about Anti-Inflammatory Agents, Non-Steroidal.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.372 |
|
|
|
-
Leung DY, Boguniewicz M. Advances in allergic skin diseases. J Allergy Clin Immunol. 2003 Mar; 111(3 Suppl):S805-12.
Score: 0.174
-
Luger T, Boguniewicz M, Carr W, Cork M, Deleuran M, Eichenfield L, Eigenmann P, F?lster-Holst R, Gelmetti C, Gollnick H, Hamelmann E, Hebert AA, Muraro A, Oranje AP, Paller AS, Paul C, Puig L, Ring J, Siegfried E, Spergel JM, Stingl G, Taieb A, Torrelo A, Werfel T, Wahn U. Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants. Pediatr Allergy Immunol. 2015 Jun; 26(4):306-15.
Score: 0.100
-
Abramovits W, Boguniewicz M. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults. J Drugs Dermatol. 2006 Mar; 5(3):236-44.
Score: 0.053
-
Boguniewicz M. Treatment options and new therapeutic approaches in atopic dermatitis. Dermatol Nurs. 2003 Aug; Suppl:12-8.
Score: 0.045
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|